Lenomorelin (ghrelin)
Also called ghrelin, human ghrelin, acyl-ghrelin, lenomorelin acetate and OXE1031, 2, 10, 17

Lenomorelin is not a new drug. It is the official drug name for ghrelin, the body's own hunger hormone. When ghrelin is made as a medicine, the World Health Organization's naming system calls it lenomorelin, and FDA's substance register lists "ghrelin" and "human ghrelin" as the same thing.1 Ghrelin is a 28-amino-acid peptide made mainly in the stomach. A fatty octanoyl group on its third amino acid is needed for it to work.2 Given into a vein, it raises appetite and growth hormone within minutes.3, 4 Small trials tested it for wasting in cancer, lung and heart disease, with mixed results.6, 7, 8 It is not approved anywhere, and there is no legal US source.
Drugs that copy ghrelin: anamorelin, macimorelin, MK-677 and ipamorelin. See every peptide's status in the regulatory tracker.
In this guide
At a glance
| What it is | Human ghrelin: a natural 28-amino-acid hormone with an octanoyl group on serine 3. Lenomorelin is its official drug name (INN)1, 2 |
|---|---|
| Given | By IV infusion or injection in studies. Active ghrelin lasts about 9 to 13 minutes in the blood4 |
| Best evidence | Small randomized studies: food intake rose 28% in 9 healthy people and 31% in 7 people with cancer during an infusion3, 5 |
| Mixed or weak | Wasting in COPD: weight rose, but strength and walking didn't in the main analysis. Heart failure: one 10-person study6, 8 |
| No human evidence for | Muscle, fat loss or anti-aging in healthy people |
| Main risks | Few known from short studies. Raises growth hormone sharply and changes blood sugar and insulin slightly. No long-term safety data4 |
| Legal status | Not approved anywhere. Can't be compounded in the US. No legal consumer source11, 12 |
| In sport | Banned at all times (WADA S2.2.4, named as "lenomorelin (ghrelin)")14 |
| Typical cost | No legal source to price |
Where to get it
MoveWell sells nothing and earns nothing from this page. There is no legal way to buy ghrelin for personal use in the US. Why
Not approved, not part of any approved drug and not on FDA's compounding nomination lists, so US pharmacies can't make it.11, 12
WhyGhrelin is given in small hospital studies, usually to answer physiology questions rather than to treat anything.16
See the studiesMolecular structure
A chain of 28 amino acids. The serine at position 3 carries an 8-carbon fatty acid, an octanoyl group, attached as an ester. This schematic shows one bead per amino acid, because an all-atom drawing of 28 residues is too small to read.

Serine 3 and its octanoyl group, needed for activity
- Sequence
- GSSFLSPEHQRVQQRKESKKPPAKLQPR (*Ser3 octanoylated)
- Length
- 28 amino acids
- Formula
- C149H249N47O42
- Weight
- 3370.9 g/mol
- CAS
- 258279-04-8
- FDA UNII
- UXG268Q86R (acetate: 4492AYV7VO)
Formula and weight are for the octanoylated free peptide, calculated with RDKit from the sequence plus the octanoyl ester. Identifiers from FDA's substance register.1, 2, 17
What it is
Lenomorelin and ghrelin are the same molecule. Ghrelin is the name scientists gave the hormone. Lenomorelin is its International Nonproprietary Name, the official generic name used when a substance is treated as a drug. FDA's substance register lists lenomorelin as the preferred name, with ghrelin, human ghrelin and acyl-ghrelin as synonyms.1 The "‑morelin" ending is shared by man-made drugs that act on the same receptor, such as anamorelin, macimorelin and ipamorelin.14
Japanese researchers found ghrelin in 1999 while searching for the natural partner of the "growth hormone secretagogue receptor," a receptor that synthetic growth hormone boosters were already known to hit. They purified a 28-amino-acid peptide from rat stomach and showed that its octanoyl group on serine 3 was essential for activity.2
Ghrelin is often called the hunger hormone, because giving it to people makes them eat more.3 Companies have tried to turn it into a medicine. Asubio tested a ghrelin drug, SUN11031, for wasting in lung disease, and Oxeia has tested OXE103, a synthetic version of human ghrelin, for concussion. Neither has reached approval.8, 9, 10
How it works
- Growth hormone. It switches on the growth hormone secretagogue receptor. In healthy men, a single IV dose raised growth hormone sharply within minutes.2, 4
- Appetite. During an infusion, healthy people ate 28% more at a buffet and rated themselves hungrier. Stomach emptying didn't change.3
- Short-lived. Active ghrelin has a half-life of about 9 to 13 minutes, which is why studies use infusions or repeated injections.4
- The octanoyl group matters. Without it, the peptide loses its activity at the receptor.2
Evidence map
Each claimed use is graded separately. A grade measures how much evidence exists, not whether the result was good news.
Consistent in small randomized crossover studies, during a single infusion
One randomized trial of 42 people on chemotherapy, and one of 7 with cancer
A 214-person phase 2 trial: weight rose, but strength and walking didn't in the main analysis
One 3-week study of 10 patients. Heart pumping rose modestly
One small open, non-randomized study of 19 people, published in 2025
No study found
Scale: 5 FDA-approved, 4 strong human, 3 limited human, 2 animal or lab only, 1 anecdotal. Concussion is graded 3, the lowest human grade, because the only study was small, open and not randomized.
Key studies
| Use | Study | Model | Finding |
|---|---|---|---|
| Appetite | Wren 20013 | Human RCT, crossover n=9 healthy | IV infusion vs saline. Buffet intake up 28%. Hunger ratings higher |
| Safety and dosing | Akamizu 20044 | Human RCT n=18 healthy men | Single IV doses. Large growth hormone rise. Side effects no more common than on placebo, and brief |
| Cancer appetite | Neary 20045 | Human RCT, crossover n=7 | Energy intake up 31% during infusion. No side effects seen |
| Chemotherapy | Hiura 20127 | Human RCT n=42 | One week of IV ghrelin with cisplatin for esophageal cancer. Food intake 18.2 vs 12.7 kcal/kg/day; fewer anorexia and nausea events |
| Heart failure | Nagaya 20046 | Human n=10, before and after | IV twice daily for 3 weeks. Ejection fraction 27% to 31%; noradrenaline fell |
| COPD wasting | SUN11031 (ghrelin drug) phase 2, 20118, 9 | Human RCT n=214 | 12 weeks. Weight up 1.5 to 2.5 kg from baseline (placebo change not reported). No strength or walking gain in the main analysis; low dose did worse on walking |
| Concussion | OXE103, Rippee 202510 | Human, open n=19 (13 vs 6) | Patients chose OXE103 or standard care. Symptom scores fell more on OXE103 (85% vs 33% responders). Not randomized; no p-values |
Almost all of these studies lasted from a few hours to 12 weeks. None tested ghrelin in healthy people for muscle, fat loss or aging.
By goal
Pick your goal to see what the evidence supports.
| Goal | Human evidence | Result |
|---|---|---|
| Eat more, short term | Small RCTs, single infusions | Yes, about 30% more at one meal |
| Weight in cancer or COPD | Small RCTs, up to 12 weeks | Weight up; strength not shown |
| Muscle or anti-aging | None found | Unknown |
How it's used
Ghrelin has no approved dose for any use, and we don't give one.
In most studies it was given into a vein, as a short infusion or injection, by research teams who tracked blood levels and side effects. The COPD trial used injections under the skin twice a day.3, 4, 6, 9 Because active ghrelin clears from the blood within minutes, it has never been a practical daily treatment.4 That short life is one reason drug makers developed longer-lasting pills such as anamorelin. We report this as information, not instruction.
Side effects and who should avoid it
- Short studies looked safe. In 18 healthy men, side effects were brief and no more common than on placebo. Seven people with cancer had no side effects.4, 5
- Hormone changes. It sharply raises growth hormone and slightly changes blood sugar and insulin.4
- No long-term data. The longest trials we found lasted 12 weeks.8
- Research vials. Online products aren't checked for purity, dose or whether the octanoyl group is intact, which the hormone needs to work.2, 15
- Who should avoid it. Anyone outside a supervised study. There are no safety data for pregnancy, breastfeeding, children, diabetes or cancer outside trials.
Compared with
| Ghrelin | Anamorelin | Macimorelin | MK-677 | |
|---|---|---|---|---|
| What it is | Natural 28-amino-acid hormone | Small molecule | Peptide-like small molecule | Small molecule |
| Taken | IV in studies | Daily pill | One drink, for a test | Daily pill |
| Approved | Nowhere | Japan, for cancer cachexia | US and EU, as a diagnostic test | Nowhere |
| In sport | Banned | Banned | Banned | Banned |
Sources: Ono,18 Macrilen label,19 WADA 2026 list.14 See our guides to anamorelin, macimorelin, MK-677 and ipamorelin.
Stacks
We found no study combining ghrelin with other growth hormone peptides or ghrelin-receptor drugs such as ipamorelin or MK-677. They act on the same receptor, so a stack adds risk without known benefit.
Myths vs evidence
All options
MoveWell sells nothing and has no commercial link on this page. Checked November 1, 2026
| Route | Status | Why |
|---|---|---|
| Prescription drug | None | Not approved anywhere1 |
| Compounding pharmacy | Not allowed | Not on the 503A list, not part of an approved drug, and not on FDA's nomination lists11, 12 |
| Telehealth | None found | Superpower, which offers compounded peptides, doesn't list it20 |
| Clinical trial | Occasional | Small university studies, often in healthy volunteers or after surgery16 |
Research use only vials
We don't list sellers. "Research use only" ghrelin is sold outside FDA's drug rules, with no check on purity, dose or acylation. In August 2026 FDA warned five peptide sellers that the label doesn't excuse products clearly meant for people.15
Legal status history
Newest first.
- Current statusNot approved anywhere. Can't be compounded in the US. Not covered by the HHS peptide policy. Banned in sport.11, 12, 13, 14
- No late-stage trial found. The concussion study's authors call for a larger randomized, placebo-controlled trial.10
- HHS enforcement discretion policy covers six peptides. Ghrelin is not one of them.13
- FDA's list of substances nominated for 503A compounding still doesn't include ghrelin or lenomorelin.11
- Open, non-randomized concussion study of OXE103 (synthetic ghrelin) published, after a Nov 2023 press release.10
- Randomized trial of ghrelin during chemotherapy published.7
- SUN11031 phase 2 results in COPD wasting presented: weight up, function not.8
- Ghrelin discovered and published in Nature.2
FAQ
Is lenomorelin the same as ghrelin?
Yes. Lenomorelin is the official generic drug name for human ghrelin. FDA's substance register lists ghrelin as a synonym.
Is it FDA-approved?
No. Ghrelin isn't approved as a drug anywhere.
Can I get it legally in the US?
No, outside a clinical study. Pharmacies can't compound it, and "research use only" vials aren't legal for human use.
Does it build muscle?
Not shown. It raises growth hormone and appetite in the short term, but a 12-week trial in COPD found weight gain without better strength or walking.
What dose do people use?
We don't give one. Studies used IV doses under medical supervision.
Can athletes use it?
No. WADA names lenomorelin (ghrelin) under S2.2.4, banned in and out of competition.
How is it different from anamorelin, macimorelin and MK-677?
Those are man-made drugs that act on ghrelin's receptor and work by mouth. Ghrelin is the natural hormone, breaks down in minutes and has to be injected or infused.
References
20 sources, with links
- FDA Global Substance Registration System. Lenomorelin (INN), UNII UXG268Q86R; synonyms ghrelin, human ghrelin, acyl-ghrelin; CAS 258279-04-8. precision.fda.gov
- Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402(6762):656–660. PMID 10604470
- Wren AM et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86(12):5992. PMID 11739476
- Akamizu T, Takaya K, Irako T, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol 2004;150(4):447–455. Library record
- Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004;89(6):2832–2836. DOI 10.1210/jc.2003-031768
- Nagaya N et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004;110(24):3674–3679. DOI 10.1161/01.CIR.0000149746.62908.BB
- Hiura Y et al. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study. Cancer 2012. DOI 10.1002/cncr.27430, PMID 22282373; summary: HealthDay
- MDedge. Mixed results for ghrelin in COPD patients with cachexia (Mar 16, 2011; SUN11031 phase 2 results). mdedge.com
- ClinicalTrials.gov. NCT00698828: SUN11031 in cachexia associated with chronic obstructive pulmonary disease (COPD). clinicaltrials.gov
- Rippee M, Wyand M, Chen J, et al. The injection of ghrelin (OXE-103) improves subacute concussion symptom burden and quality of life. Neurotrauma Rep 2025;6(1):402–412. DOI 10.1089/neur.2025.0038. Earlier press release: Oxeia Biopharmaceuticals, Nov 27, 2023, biopharmadive.com
- FDA. Bulk drug substances nominated for use in compounding under section 503A, Categories 1 to 3 (updated May 14, 2026). fda.gov
- FDA. Bulk drug substances used in compounding under section 503A of the FD&C Act (current as of May 14, 2026). fda.gov
- HHS. 503A peptide enforcement discretion policy, Appendix B (Oct 28, 2026). hhs.gov
- World Anti-Doping Agency. 2026 Prohibited List, S2.2.4 growth hormone secretagogues (copy hosted by SEGAS). PDF
- ArentFox Schiff. RUO-ined: five peptide vendors learn research use only is not a legal strategy (Sep 18, 2026; on FDA warning letters of Aug 24, 2026). Link
- ClinicalTrials.gov. NCT05189353: The importance of ghrelin for glucose metabolism after sleeve gastrectomy (Hvidovre University Hospital; completed, 22 patients). clinicaltrials.gov
- NDC List. Lenomorelin acetate, UNII 4492AYV7VO (from FDA's substance register). ndclist.com
- Ono Pharmaceutical. ONO receives manufacturing and marketing approval of Adlumiz, a ghrelin receptor agonist, for the treatment of cancer cachexia (Jan 22, 2021). ono-pharma.com
- FDA. Macrilen (macimorelin) for oral solution, prescribing information, NDA 205598 (revised Jul 2026). fda.gov
- Superpower. Peptides page (checked Nov 1, 2026; ghrelin and other ghrelin-receptor drugs not listed). Link
This page is for education and is not medical advice. Ghrelin (lenomorelin) is not approved as a drug. Talk to a clinician about appetite or weight loss caused by illness.